Description
PRINCIPIO ACTIVO: CLONIXINATO DE LISINA 100 MG
PRINCIPIO ACTIVO: PIMECROLIMUS 0
dolor articular o muscular
Presentación en caja con 100 jeringas desechables de plástico Contiene aguja extra delgada No contiene látex Modalidad de uso manual
generalmente antes de iniciar la quimioterapia o cirugía
PHARMACEN SOL. 100 MG. FCO. C/15 ML. NIFUROXAZIDA PRINCIPIO ACTIVO: CLONIXINATO DE LISINA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
